您现在的位置: 首页> 研究主题> 肺损伤,急性

肺损伤,急性

肺损伤,急性的相关文献在1999年到2022年内共计265篇,主要集中在内科学、基础医学、中国医学 等领域,其中期刊论文234篇、专利文献37777篇;相关期刊43种,包括中国病理生理杂志、中华危重病急救医学、中国中西医结合急救杂志等; 肺损伤,急性的相关文献由954位作者贡献,包括纪云霞、蒋王林、吕长俊等。

肺损伤,急性—发文量

期刊论文>

论文:234 占比:0.62%

专利文献>

论文:37777 占比:99.38%

总计:38011篇

肺损伤,急性—发文趋势图

肺损伤,急性

-研究学者

  • 纪云霞
  • 蒋王林
  • 吕长俊
  • 张健鹏
  • 温尧林
  • 钱桂生
  • 樊毫军
  • 邱海波
  • 陈正堂
  • 刘书盈
  • 期刊论文
  • 专利文献

搜索

排序:

年份

    • Fan Longxin; Han Yanzhou; Zhu Haihong; Guo Yamin
    • 摘要: Objective To investigate whether the expression of metal matrix protease-9 (MMp-9) changes with altitude in severe acute pancreatitis (SAP) lung injury by establishing SAP model in rats.The related indexes of pancreas and lung injury and MMp-9 were measured.Methods 280 SPF male Wistar rats were randomly assigned to different altitude groups to establish SAP model,then the serum amylase (AMY) content of each group were detected.The degree of pancreatic injury and pancreatic pathological score were observed under light microscope.The expression level of MMP-9 in lung tissues was measured and analyzed by statistical methods.Results (1) At the same altitude,the expression of MMP-9 in each time group increased with time,with statistically significant difference (P ≤ 0.05).(2) AMY value,pathological score of pancreas and expression of MMP-9 in lung tissue increased with the altitude in the same time group at different altitudes,with statistically significant difference (P ≤ 0.05).Conclusions The higher the altitude,the more severe the damage of SAP and lung,and the higher the expression level of MMP-9.%目的 通过建立大鼠急性重症胰腺炎(SAP)模型,测定胰腺及肺损伤相关指标及基质金属蛋白酶-9 (MMP-9),探讨SAP肺损伤中MMP-9表达水平是否随海拔高度变化而变化.方法 将280只SPF级雄性Wistar大鼠随机分到不同海拔组,建立SAP模型,测定各小组血清中淀粉酶(AMY)的含量;光镜下观察胰腺损伤程度及进行胰腺病理评分、观察肺组织损伤情况,测出肺脏组织中MMP-9的表达水平,并进行统计分析.结果 (1)同一海拔高度下,各时间组的MMP-9表达、AMY值、胰腺组织病理评分随时间延长而增加,差异有统计学意义(P≤0.05);(2)不同海拔同一时间组内,AMY值、胰腺组织病理评分、肺脏组织中MMP-9表达随海拔的增高而增加,差异有统计学意义(P≤0.05).结论 海拔越高,SAP大鼠的肺损伤程度越重,MMP-9表达水平越高.
    • WANG Xiaoyu; ZHAO Yadong; CHENG Huiping
    • 摘要: 目的 探讨盐酸戊乙奎醚对脓毒症大鼠急性肺损伤肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)、中性粒细胞弹性蛋白酶(NE)表达的影响.方法 健康雄性SD大鼠60只,随机分为3组(n=20):假手术组(Sham组)、脓毒症组(CLP组)、盐酸戊乙奎醚组(PHC组).采用盲肠结扎穿孔术(CLP)复制脓毒症大鼠模型.观察各组大鼠术后一般情况,观察造模后5 d内3组动物存活率,同时于造模后术后12 h,取血标本,并留取支气管肺泡灌洗液及肺组织进行检测.应用普通光镜及电镜检测各组肺组织的病理变化情况,同时计算肺湿/干重比(W/D).采集血标本检测血气指标,采用ELISA法检测支气管肺泡灌洗液(BALF)中TNF-α、IL-6和NE的水平.结果 与Sham组比较,CLP组、PHC组TNF-α、IL-6、NE表达升高(P<0.05);与CLP组比较,PHC组TNF-α、IL-6、NE表达降低(P<0.05).结论 盐酸戊乙奎醚能够有效降低大鼠体内TNF-α、IL-6和NE的水平,能显著减轻肺损伤的病理损害,对脓毒症大鼠的肺损伤有保护效果.
    • 李丹; 丛竹凯; 吕向鹏; 吴长毅; 陶一帆; 朱曦
    • 摘要: 急性肺损伤(ALI)及其严重形式急性呼吸窘迫综合征(ARDS)是临床常见危重症,发病诱因复杂多样,主要病理特征是气血屏障破坏导致的弥漫性炎性、蛋白性肺水肿.活性氧(ROS)可氧化脂质、蛋白质、核酸等大分子物质从而介导氧化损伤.在产生ROS的诸多体系中,还原型辅酶Ⅱ(NADPH)氧化酶介导的ROS是其主要来源,其功能亚基、跨膜亚基NOX家族在肺组织中的分布具有细胞类型依赖性.NOX来源的ROS参与肺组织的防御功能并且与ALI/ARDS的发生发展相关.本文主要从NOX家族在肺组织中的细胞分布、活化因素及与ALI发生发展的关系进行综述.%Acute?lung?injury?(ALI)?and?its?severe?form,?acute?respiratory?distress?syndrome?(ARDS),?are?common?critical?syndromes.?The?causes?of?the?syndrome?are?complex?and?diverse.?The?main?pathological?features?are?the?diffuse?inflammatory?and?protein-rich?pulmonary?edema?caused?by?destruction?of?the?blood-air?barrier.?Reactive?oxygen?species?(ROS)?mediate?oxidative?damage?by?oxidizing?bio-macromolecules,?including?lipids,?proteins?and?nucleic?acid.?Among?many?systems?producing?ROS,?nicotinamide-adenine?dinucleotide?phosphate?(NADPH)?oxidase-mediated?ROS?is?the?main?source,?and?its?functional?subunit?is?the?transmembrane?subunit?NOX?family.?The?distribution?of?NOX?family?proteins?in?lung?tissue?is?cell?type?dependent.?NOX-derived?ROS?is?involved?in?the?defense?function?of?lung?tissue?and?related?to?the?occurrence?and?development?of?ALI/ARDS.?This?review?mainly?describes?the?cell?distribution,?activation?factors,?and?its?relationship?with?the?occurrence?and?development?of?ALI?of?the?NOX?family.
    • 李丹1; 丛竹凯1; 吕向鹏2; 吴长毅3; 陶一帆3; 朱曦1
    • 摘要: 急性肺损伤(ALI)及其严重形式急性呼吸窘迫综合征(ARDS)是临床常见危重症,发病诱因复杂多样,主要病理特征是气血屏障破坏导致的弥漫性炎性、蛋白性肺水肿。活性氧(ROS)可氧化脂质、蛋白质、核酸等大分子物质从而介导氧化损伤。在产生ROS的诸多体系中,还原型辅酶Ⅱ(NADPH)氧化酶介导的ROS是其主要来源,其功能亚基、跨膜亚基NOX家族在肺组织中的分布具有细胞类型依赖性。NOX来源的ROS参与肺组织的防御功能并且与ALI/ARDS的发生发展相关。本文主要从NOX家族在肺组织中的细胞分布、活化因素及与ALI发生发展的关系进行综述。
    • 郭利敏; 郭珊; 徐震; 马欢欢
    • 摘要: Objective To investigate the effect of Tanreqing injection on the concentrations of serum inflammatory mediators in patients with acute lung injury (ALI). Methods One hundred and thirty-six patients with ALI by clinical diagnosis admitted to Xinxiang Central Hospital from December 2013 to December 2017 were enrolled, they were randomly divided into a conventional treatment group and a Tanreqing treatment group, 68 cases in each group; in the mean time, 50 healthy subjects having undertaken physical examinations in this hospital were assigned in the healthy control group. In the conventional and Tanreqing treatment groups, the primary diseases of patients were treated, combined with corticosteroid and antiseptic drugs to combat against infection, and nutrition support, fluid supplement and symptomatic therapy were also used. The patients in the Tanreqing treatment group beside received conventional treatment, additionally they were treated with Tanreqing injection 20 mL in 0.9% Sodium Chloride solution or 5% Glucose 250 mL intravenous drip in 2 hours, once daily. And, the difference of each index was evaluated on the 7th day after the patient entering the group. The concentrations of serum interleukin (IL-1, IL-6) and tumor necrosis factor-α (TNF-α) were detected for the patients in two groups and controls by using the enzyme linked immunosorbent assay (ELISA) and radioimmunoassay (RIA), respectively. Meanwhile, the changes of arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), oxygenation index (PaO2/FiO2), pH value, systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were observed in the conventional and Tanreqing treatment groups. Results The concentrations of serum IL and TNF-α in the conventional and Tanreqing treatment groups before treatment were significantly higher than those in healthy controls [IL-1 (ng/L): 128.45±27.91, 131.12±26.26 vs. 24.55±6.12, IL-6 (ng/L): 65.77±7.21, 64.08±7.05 vs. 19.13±4.55, TNF-α (ng/L): 41.24±7.01, 40.07±6.76 vs. 10.62±2.65, all P < 0.05]. Moreover, the levels of IL-1, IL-6, TNF-α, PaCO2, SVR and PVR in the conventional and Tanreqing treatment groups after treatment were significantly lower than those before treatment, and the levels of PaO2 and PaO2/FiO2were obviously increased compared with those before treatment, and the changes of the above indicators were more significant in the Tanreqing treatment group [IL-1 (ng/L): 75.67±18.58 vs. 101.22±21.13, IL-6 (ng/L):42.05±5.31 vs. 54.02±6.89, TNF-α (ng/L): 19.63±5.19 vs. 30.35±4.55, PaO2(mmHg, 1 mmHg = 0.133 kPa):93.06±7.95 vs. 72.66±8.04, PaCO2(mmHg): 42.32±2.44 vs. 50.25±3.43, PaO2/FiO2(mmHg): 316.28±16.73 vs. 256.33±14.25, SVR (kPa·s·L-1): 0.73±0.09 vs. 0.81±0.10, PVR (kPa·s·L-1): 0.08±0.02 vs. 0.10±0.02, all P <0.05]. The pH value was restored to normal (conventional treatment group was 7.37±0.27, Tanreqing treatment group was 7.41±0.31). Conclusion Tanreqing injection can reduce the concentrations of serum inflammatory mediators, significantly improve the blood gas and hemodynamic indexes, and reduce inflammatory reaction in the patients with ALI.%目的 观察痰热清注射液对急性肺损伤(ALI)患者血清炎症介质水平的影响.方法 收集新乡市中心医院2013年12月至2017年12月临床确诊的ALI患者136例,将患者按随机数字表法分为常规治疗组和痰热清治疗组,每组68例;以同期本院50例健康体检者作为健康对照组.常规治疗组和痰热清治疗组患者均进行原发病治疗,联合激素和抗菌药物抗感染、营养和补液以及对症支持等综合疗法.痰热清治疗组在常规治疗基础上将痰热清注射液20 mL加入0.9%氯化钠注射液或5%葡萄糖注射液250 mL中2 h内静脉滴注(静滴),每日1次.于入组后7 d后评价各指标的差异.采用酶联免疫吸附试验(ELISA)和放射免疫分析法(RIA)检测3组受试者血清白细胞介素(IL-1、IL-6)和肿瘤坏死因子-α(TNF-α)水平;并记录常规治疗组和痰热清治疗组患者动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、氧合指数(PaO2/FiO2)、pH值水平以及体循环阻力(SVR)及肺血管阻力(PVR)的变化.结果 常规治疗组和痰热清治疗组治疗前血清IL和TNF-α水平均明显高于健康对照组〔IL-1(ng/L):128.45±27.91、131.12±26.26比24.55±6.12,IL-6 (ng/L):65.77±7.21、64.08±7.05 比 19.13±4.55,TNF-α(ng/L):41.24±7.01、40.07±6.76 比 10.62±2.65,均P<0.05〕.常规治疗组和痰热清治疗组治疗后IL-1、IL-6、TNF-α、PaCO2、SVR和PVR均较治疗前明显降低,PaO2和PaO2/FiO2均较治疗前明显升高,但以痰热清治疗组上述指标的变化较常规治疗组更显著〔IL-1(ng/L):75.67±18.58 比 101.22±21.13,IL-6(ng/L):42.05±5.31 比 54.02±6.89,TNF-α(ng/L):19.63±5.19比30.35±4.55,PaO2(mmHg,1 mmHg=0.133 kPa):93.06±7.95比72.66±8.04,PaCO2(mmHg):42.32±2.44比50.25±3.43,PaO2/FiO2(mmHg):316.28±16.73比256.33±14.25,SVR(kPa·s·L-1):0.73±0.09比0.81±0.10,PVR(kPa·s·L-1):0.08±0.02比0.10±0.02,均P<0.05〕,pH值基本恢复正常(常规治疗组为7.37±0.27,痰热清治疗组为7.41±0.31).结论 痰热清注射液能降低ALI患者血清炎症介质水平,显著改善患者血气分析和血流动力学指标,降低炎症反应.
    • 李小茜; 杨爱东
    • 摘要: 急性肺损伤(ALI)及其诱发的急性呼吸窘迫综合征(ARDS)是临床许多危重疾病发生急性呼吸衰竭的主要原因,是临床重大呼吸系统疾病之一,病死率一直居高不下.其病理基础常表现为肺内失控的炎症反应所致的肺毛细血管膜损伤,肺水肿及透明膜形成.本文从炎症、氧化应激、细胞凋亡、自噬等角度全方位综合概述ALI的发病机制,阐释ALI的发生与炎症反应失控、细胞因子释放、氧化与抗氧化系统失衡、以及不同诱因导致的细胞自噬的关系.归纳总结ALI的中医药治疗方法、中药复方等研究概况,根据"肺与大肠相表里"理论,提出以宣肺通腑法防治ALI,从调控炎症反应与自噬途径的角度,揭示理论内涵,为ALI基础研究及中药新药的开发提供方向.%Acute lung injury (ALI) and its evoked acute respiratory distress syndrome (ARDS) are the main causes of acute respiratory failure (ARF) in many clinical severe diseases, so that ALI is one of the clinical serious respiratory diseases. The mortality of ALI is persisting at high level without any lowering. And its basic pathological manifestations often show injury of pulmonary capillary membrane caused by uncontrolled inflammation, pulmonary edema and formation of transparent membrane. In this article, from the point of view of inflammation, oxidation stress, cell apoptosis, autophagy, etc to comprehensively summarize the pathogenesis of ALI, explaining the relationships between the occurrence of ALI and the uncontrolled inflammation, cytokines release, the unbalance of oxidation and anti-oxidation system, and different inducing factors leading to cellular autophagy. Moreover, the general research situation of traditional Chinese medicine and Chinese herbal compound prescription for treatment of ALI was summarized. According to the TCM theory of "lung and the large intestine being interior-exteriorly related", the TCM method of Xuanfeitongfu method was proposed to be used for prevention and treatment of ALI, and from the point of view of inflammatory reaction regulation and autophagy pathway, the theoretical connotation was revealed, aiming to provide a direction for basic research and development of new traditional Chinese medicine for treatment of ALI.
    • 毕兴华; 周龙媛; 蔡畅; 漆勇; 李炎
    • 摘要: 目的 探讨细胞游离血红蛋白(CFH)对小鼠脓毒症肺损伤的影响.方法 将60只BALB/c小鼠分为假手术组(A组)、脓毒症组(B组)、脓毒症+生理盐水组(C组)、脓毒症+ CFH组(D组),每组15只.酶联免疫吸附试验(ELISA)检测肺泡灌洗液和血清肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)水平.测定肺组织湿/干比值,苏木素-伊红染色观察肺组织病理改变并评分.免疫组织化学检测核因子-κB(NF-κB)及其抑制蛋白-α(IκB-α)、血红素氧合酶-1(HO-1)及晚期糖基化终末产物受体(RAGE)的表达.结果 各组小鼠肺组织水肿、病理改变和炎症反应严重程度由轻至重依次为A组,B、C组及D组.与B、C组比较,D组小鼠肺组织NF-κB、HO-1及RAGE表达均上调,IκB-α表达下调,差异均有统计学意义(P<0.05);而B、C组间肺组织NF-κB、HO-1及RAGE水平比较,差异均无统计学意义(P>0.05).结论 CFH加重小鼠脓毒症肺损伤的机制可能与HO-1及RAGE表达上调有关.
    • 刘涛; 谢媛; 徐梦桐; 郑粉双
    • 摘要: Objective To investigate the protective effect of thalidomide on acute lung injury (ALI) induced by paraquat (PQ) poisoning in rats and its possible mechanism. Methods Sixty SPF Wistar rats were randomly divided into six groups with 10 rats in each group. The rat model of PQ poisoning was reproduced by intraperitoneal injection of PQ solution 20 mg/kg (PQ model group), and the rats were treated by intraperitoneal injection of gradient thalidomide (50, 100, 200 mg/kg treatment groups) 30 minutes later continuously for 3 days. The normal saline (NS) control group and thalidomide control group (thalidomide 200 mg/kg) were established. After 3 days, the abdominal aorta blood was collected, and the superoxide dismutase (SOD) activity was determined by hydroxylamine method, serum malondialdehyde (MDA) content was determined by thiobarbituric acid method. The rats were sacrificed for lung tissue, the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were determined by enzyme-linked immunosorbent assay (ELISA). The phosphorylation levels of p65 and inhibitor-α of nuclear factor-κB (NF-κB) (IκB-α), which were the NF-κB signaling pathway proteins, were determined by Western Blot. The pathological changes in lung tissue were observed under light microscope by hematoxylin-eosin (HE) staining. Results Under microscope, obvious congestion of pulmonary interstitial and alveolar septum, a large number of inflammatory cells infiltration and thickened alveolar wall were observed after 3 days of PQ poisoning, and the congestion of pulmonary interstitial and alveolar septum, edema and inflammatory cells infiltration in the lung tissue were significantly reduced after treatment of 50, 100, 200 mg/kg thalidomide, but compared with NS control group, there was still a small amount of edema fluid, inflammatory cells and erythrocytes in the lungs tissue. Compared with the NS control group, serum MDA content and the levels of TNF-α and IL-6, and the phosphorylation of p65 and IκB-α in lung tissue were significantly increased after PQ exposure, and the activity of serum SOD was significantly decreased. Treatment with 50, 100, 200 mg/kg thalidomide could significantly reduce the levels of MDA, TNF-α, IL-6, and phosphorylation of IκB-α and p65, and increase SOD activity, in a dose-dependent manner, and the levels were significantly different from PQ model group [MDA (mmol/L): 8.26±1.20, 6.72±1.18, 5.51±1.44 vs. 9.02±1.03, TNF-α (ng/mg): 3.00±0.14, 1.84±0.18, 1.58±0.11 vs. 3.30±0.14, IL-6 (ng/mg): 1.26±0.04, 1.06±0.04, 0.97±0.08 vs. 1.97±0.07, p-p65/p65: 6.01±0.35, 3.64±0.15, 2.89±0.18 vs. 6.34±0.23, p-IκB-α/IκB-α: 2.27±0.13, 2.14±0.22, 1.52±0.14 vs. 2.96±0.20, SOD (kU/L): 195.7±19.3, 207.1±25.6, 225.8±23.1 vs. 188.2±26.6, all P < 0.05]. There was no significant effect on lung by 200 mg/kg thalidomide alone. Conclusion Thalidomide has a protective effect on ALI induced by PQ poisoning in rats in a dose-dependent manner, the mechanism may be achieved by reducing the level of oxygen free radicals, reducing the inflammatory factor and inhibiting the IκB-α/NF-κB signal pathway activation.%目的 探讨沙利度胺对百草枯(PQ)中毒急性肺损伤(ALI)大鼠的保护作用及其可能机制.方法 将60 只SPF级Wistar大鼠按随机数字表法分为6组,每组10只.采用腹腔注射PQ溶液20 mg/kg建立大鼠PQ中毒模型(PQ模型组),30 min后腹腔注射梯度沙利度胺进行干预(50、100、200 mg/kg干预组),连续3 d;并设立生理盐水(NS)对照组和沙利度胺对照组(给予200 mg/kg).分别于3 d后取大鼠腹主动脉血,采用羟胺测定法检测血清超氧化物歧化酶(SOD)活性,采用硫代巴比妥酸测定法检测血清丙二醛(MDA)含量.处死大鼠取肺组织,采用酶联免疫吸附试验(ELISA)检测肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)含量;采用蛋白质免疫印迹试验(Western Blot)检测核转录因子-κB(NF-κB)信号通路蛋白p65和NF-κB抑制蛋白-α(IκB-α)的磷酸化水平;经苏木素-伊红(HE)染色后,光镜下观察肺组织病理学改变.结果 PQ染毒3 d后可见大鼠肺间质及肺泡间隔明显充血,有大量炎性细胞浸润,肺泡壁增厚;而给予50、100、200 mg/kg沙利度胺干预后,大鼠肺间质和肺泡间隔充血、水肿及炎性细胞浸润明显减轻,但仍可见少量水肿液、炎性细胞及红细胞.与NS对照组比较,PQ染毒后血清MDA含量以及肺组织TNF-α、IL-6水平和p65、IκB-α蛋白磷酸化水平均明显升高,血清SOD活性明显降低;而给予50、100、200 mg/kg沙利度胺干预后,可呈剂量依赖性地抑制PQ染毒诱导的MDA、TNF-α、IL-6含量及p65、IκB-α蛋白磷酸化水平升高,并提高SOD活性,与PQ模型组比较差异有统计学意义〔MDA(mmol/L):8.26±1.20、6.72±1.18、5.51±1.44比9.02±1.03,TNF-α (ng/mg)为3.00±0.14、1.84±0.18、1.58±0.11比3.30±0.14,IL-6(ng/mg):1.26±0.04、1.06±0.04、0.97±0.08比1.97±0.07, p-p65/p65:6.01±0.35、3.64±0.15、2.89±0.18比6.34±0.23,p-IκB-α/IκB-α:2.27±0.13、2.14±0.22、1.52±0.14比2.96±0.20,SOD(kU/L):195.7±19.3、207.1±25.6、225.8±23.1比188.2±26.6,均P<0.05〕.单纯给予200 mg/kg沙利度胺对肺脏则无明显影响.结论 沙利度胺对PQ中毒ALI大鼠具有保护作用,并呈一定剂量依赖性,其机制可能与降低氧自由基和炎性因子水平,以及抑制IκB-α/NF-κB信号通路活化有关.
    • 周焕平; 刘美云; 吕欣
    • 摘要: Acute lung injury (ALI) is one of the most common clinical critical illnesses. Its severe stage is acute respiratory distress syndrome (ARDS), characterized by rapid onset and high mortality. There is no effective treatment. Based on many preclinical studies, mesenchymal stem cells (MSCs) have great potential as a therapeutic strategy for ALI, clinical trials are underway, and studies on the therapeutic effects of MSCs progressively deep into the molecular mechanism and continue to make new progress. However, the use of MSCs, their specific methods and risks, especially on the risk of iatrogenic tumor formation remains unresolved. In this paper, we reviewed the main problems in the application of MSCs in the treatment of ALI and the main problems in the application of MSCs in order to explore the feasibility and future direction of MSCs in the treatment of ALI.%急性肺损伤(ALI)是一种临床常见的危重病症,其发展到严重阶段为急性呼吸窘迫综合征(ARDS),患者发病急,病死率高,目前尚无有效的治疗方法,是亟待解决的医学难题之一.基于许多临床预试验结果证实,间充质干细胞(MSCs)作为ALI的有效治疗策略具有很大的应用前景,目前对MSCs治疗作用的研究从现象逐渐深入到分子机制,并不断取得新成果,临床试验也开始有了突破性的进展.然而,对于MSCs在临床中的具体应用方法和风险,特别是医源性肿瘤形成风险等仍未解决.本文针对近年来在MSCs治疗ALI的作用机制方面取得的突破性进展和临床试验应用过程中存在的主要问题进行综述,以探讨MSCs治疗ALI的可行性和未来努力方向,从而促进ALI的有效治疗.
    • 周焕平; 刘美云; 吕欣
    • 摘要: 急性肺损伤(ALI)是一种临床常见的危重病症,其发展到严重阶段为急性呼吸窘迫综合征(ARDS),患者发病急,病死率高,目前尚无有效的治疗方法,是亟待解决的医学难题之一.基于许多临床预试验结果证实,间充质干细胞(MSCs)作为ALI的有效治疗策略具有很大的应用前景,目前对MSCs治疗作用的研究从现象逐渐深入到分子机制,并不断取得新成果,临床试验也开始有了突破性的进展.然而,对于MSCs在临床中的具体应用方法和风险,特别是医源性肿瘤形成风险等仍未解决.本文针对近年来在MSCs治疗ALI的作用机制方面取得的突破性进展和临床试验应用过程中存在的主要问题进行综述,以探讨MSCs治疗ALI的可行性和未来努力方向,从而促进ALI的有效治疗.
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号